Clinical Trial: Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07620574) titled 'Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study' on May 27.

Brief Summary: The primary objective of this long-term extension study is to allow continued access to study treatment for eligible participants who are deriving clinical benefit in an Exelixis-sponsored study who do not have access to treatment locally.

Study Start Date: May 31

Study Type: INTERVENTIONAL

Condition: Cancer Renal Cell Carcinoma (RCC) Pancreatic Neuroendocrine Tumors (pNET) Extra-Pancreatic NET (epNET) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) Non-Clear Cell Renal Cell Carcinoma (nccRCC...